• 제목/요약/키워드: Mary

검색결과 3,068건 처리시간 0.033초

Rapid onset of efficacy predicts response to therapy with certolizumab plus methotrexate in patients with active rheumatoid arthritis

  • Kang, Young Mo;Park, Young-Eun;Park, Won;Choe, Jung-Yoon;Cho, Chul-Soo;Shim, Seung-Cheol;Bae, Sang Cheol;Suh, Chang-Hee;Cha, Hoon-Suk;Koh, Eun Mi;Song, Yeong-Wook;Yoo, Bin;Lee, Shin-Seok;Park, Min-Chan;Lee, Sang-Heon;Arendt, Catherine;Koetse, Willem;Lee, Soo-Kon
    • The Korean journal of internal medicine
    • /
    • 제33권6호
    • /
    • pp.1224-1233
    • /
    • 2018
  • Background/Aims: The objective of this study was to determine the efficacy and safety of add-on therapy with certolizumab pegol (CZP) in active rheumatoid arthritis (RA) patients of a single ethnicity. Methods: In this 24-week, phase 3, randomized, double-blind, placebo-controlled trial, eligible patients (n = 127) were randomized 2:1 to subcutaneous CZP + methotrexate (MTX; 400 mg at week 0, 2, and 4 followed by 200 mg every 2 weeks) or placebo + MTX. Results: At week 24, the American College of Rheumatology criteria for 20% (ACR20) response rate was significantly greater with CZP + MTX than with placebo (66.7% vs. 27.5%, p < 0.001). Differences in ACR20 response rates for CZP vs. placebo were significant from week 1 (p < 0.05) and remained significant through week 24. The CZP group reported significant improvement in physical function and disability compared to the placebo group (p < 0.001) at week 24, as assessed by Korean Health Assessment Questionnaire-Disability Index (KHAQ-DI). Post hoc analysis indicated that the proportion of patients who had ACR70 responses, Disease Activity Score 28 (DAS28) low disease activity, and DAS28 remission at week 24 was greater in CZP + MTX-treated patients who achieved a decrease in DAS28 ${\geq}1.2$ (43.8%) at week 4 than in nonresponders. Among 18 (22.2%) and 14 patients (35.0%) in CZP and placebo groups who had latent tuberculosis (TB), none developed active TB. Most adverse events were mild or moderate. Conclusions: CZP treatment combined with MTX in active RA patients with moderate to severe disease activity and an inadequate response to MTX resulted in rapid onset of efficacy, which is associated with better clinical outcome at week 24 and has an acceptable safety profile, especially in an intermediate TB-burden population.

Korean Guideline for the Prevention and Treatment of Glucocorticoid-induced Osteoporosis

  • Park, So Young;Gong, Hyun Sik;Kim, Kyoung Min;Kim, Dam;Kim, Ha Young;Jeon, Chan Hong;Ju, Ji Hyeon;Lee, Shin-Seok;Park, Dong-Ah;Sung, Yoon-Kyoung;Kim, Sang Wan
    • 대한골대사학회지
    • /
    • 제25권4호
    • /
    • pp.195-211
    • /
    • 2018
  • Background: To develop guidelines and recommendations to prevent and treat glucocorticoid (GC)-induced osteoporosis (GIOP) in Korea. Methods: The Korean Society for Bone and Mineral Research and the Korean College of Rheumatology have developed this guideline based on Guidance for the Development of Clinical Practice Guidelines ver. 1.0 established by the National Evidence-Based Healthcare Collaborating Agency. This guideline was developed by adapting previously published guidelines, and a systematic review and quality assessment were performed. Results: This guideline applies to adults aged ${\geq}19years$ who are using or plan to use GCs. It does not include children and adolescents. An initial assessment of fracture risk should be performed within 6 months of initial GC use. Fracture risk should be estimated using the fracture-risk assessment tool (FRAX) after adjustments for GC dose, history of osteoporotic fractures, and bone mineral density (BMD) results. All patients administered with prednisolone or an equivalent medication at a dose ${\geq}2.5mg/day$ for ${\geq}3months$ are recommended to use adequate calcium and vitamin D during treatment. Patients showing a moderate-to-high fracture risk should be treated with additional medication for osteoporosis. All patients continuing GC therapy should undergo annual BMD testing, vertebral X-ray, and fracture risk assessment using FRAX. When treatment failure is suspected, switching to another drug should be considered. Conclusions: This guideline is intended to guide clinicians in the prevention and treatment of GIOP.

Low-Tube-Voltage CT Urography Using Low-Concentration-Iodine Contrast Media and Iterative Reconstruction: A Multi-Institutional Randomized Controlled Trial for Comparison with Conventional CT Urography

  • Kim, Sang Youn;Cho, Jeong Yeon;Lee, Joongyub;Hwang, Sung Il;Moon, Min Hoan;Lee, Eun Ju;Hong, Seong Sook;Kim, Chan Kyo;Kim, Kyeong Ah;Park, Sung Bin;Sung, Deuk Jae;Kim, Yongsoo;Kim, You Me;Jung, Sung Il;Rha, Sung Eun;Kim, Dong Won;Lee, Hyun;Shim, Youngsup;Hwang, Inpyeong;Woo, Sungmin;Choi, Hyuck Jae
    • Korean Journal of Radiology
    • /
    • 제19권6호
    • /
    • pp.1119-1129
    • /
    • 2018
  • Objective: To compare the image quality of low-tube-voltage and low-iodine-concentration-contrast-medium (LVLC) computed tomography urography (CTU) with iterative reconstruction (IR) with that of conventional CTU. Materials and Methods: This prospective, multi-institutional, randomized controlled trial was performed at 16 hospitals using CT scanners from various vendors. Patients were randomly assigned to the following groups: 1) the LVLC-CTU (80 kVp and 240 mgI/mL) with IR group and 2) the conventional CTU (120 kVp and 350 mgI/mL) with filtered-back projection group. The overall diagnostic acceptability, sharpness, and noise were assessed. Additionally, the mean attenuation, signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), and figure of merit (FOM) in the urinary tract were evaluated. Results: The study included 299 patients (LVLC-CTU group: 150 patients; conventional CTU group: 149 patients). The LVLC-CTU group had a significantly lower effective radiation dose ($5.73{\pm}4.04$ vs. $8.43{\pm}4.38mSv$) compared to the conventional CTU group. LVLC-CTU showed at least standard diagnostic acceptability (score ${\geq}3$), but it was non-inferior when compared to conventional CTU. The mean attenuation value, mean SNR, CNR, and FOM in all pre-defined segments of the urinary tract were significantly higher in the LVLC-CTU group than in the conventional CTU group. Conclusion: The diagnostic acceptability and quantitative image quality of LVLC-CTU with IR are not inferior to those of conventional CTU. Additionally, LVLC-CTU with IR is beneficial because both radiation exposure and total iodine load are reduced.

난치성 뇌전증 환자에서 수술 전 유발전위검사 (Evoked Potentials before the Intractable Epilepsy Surgery)

  • 임성혁;박상구;백재승;김갑규;김기업;이유지
    • 대한임상검사과학회지
    • /
    • 제51권2호
    • /
    • pp.198-204
    • /
    • 2019
  • 여러가지 약물에도 발작의 증세가 조절되지 않는 난치성 뇌전증 환자에서 다양한 치료법들을 시도해 볼 수 있다. 하지만 그 중 수술적인 방법이 필요한 환자에서는 수술 전 검사를 통해 발작부위의 절제부분을 결정한다. 정확한 병변의 측정과 안전한 수술을 위해 뇌 피질에 전극 삽입술을 시행한다. 피질에 삽입된 전극으로 단순히 뇌파만을 기록하는 것이 아니라 다양한 검사를 시도해 그 부위가 갖는 기능을 확인할 수 있고 그런 검사법 중 하나로 유발전위 검사법이 있다. 2015년 1월부터 2018년 12월까지 70명의 환자를 대상으로 측정된 파형의 경향이 의미하는 바를 분석하였다. 뇌 피질에 삽입된 전극에서 기록된 체성감각유발전위는 중심고랑의 주행경로를 찾아 일차운동영역 및 일차감각영역을 피해 수술 할 수 있다. 또한 청각유발전위와 시각유발전위를 이용해 청각피질과 시각피질에서 기능적 피질의 확인과 뇌파검사상 나타난 발작초점부위와의 관계를 비교해 절제부위를 결정하는데 도움을 주고 수술 후에 발생할 수 있는 기능적 장애를 최소화 할 수 있다.

임플란트 수술용 가이드를 사용한 부분 유도 임플란트 수술의 정확도 평가: 증례보고 (An assessment of accuracy of half-guided implant surgery using implant surgical guide: A case report)

  • 김충길;이원섭;권호범
    • 대한치과보철학회지
    • /
    • 제57권2호
    • /
    • pp.150-159
    • /
    • 2019
  • 무치악 환자의 치료에서 치과용 임플란트를 이용한 보철치료는 현재 널리 사용되고 있는 치료 방법 중 하나이다. 임플란트를 적절한 위치에 정확히 식립하기 위해 최근 임플란트 수술용 가이드를 이용하여 임플란트 수술의 정확도를 향상시키는 방법이 소개되어 폭넓게 사용되고 있다. 임플란트 수술 시 임플란트 수술용 가이드를 적용하는 수준에 따라 완전 유도 임플란트 수술과 부분 유도 임플란트 수술로 구분할 수 있다. 비록 완전 유도 임플란트 수술이 더 높은 정확도를 보이는 것은 사실이나 수술상황에서의 다양한 임상적 환경 등으로 인해서 부분 유도 임플란트 수술이 종종 시행된다. 이 증례는 치아파절과 치주염 등으로 치아를 상실하게 된 부분무치악 환자에서 임플란트와 고정성보철물을 이용해서 보철 수복 치료를 시행한 사례이다. 임플란트 수술 과정에서 임플란트 수술용 가이드를 사용해서 부분 유도 임플란트 수술을 시행하였으며, 임플란트 수술 계획과 수술 결과 간의 정확도에 대한 분석을 시행하여 소개하였다.

작업치료사의 우울감에 영향을 미치는 감정노동 요인 (Emotional Labor Factors Affecting Depressive Mood in Occupational Therapists)

  • 오서연;구정완
    • 대한작업치료학회지
    • /
    • 제26권4호
    • /
    • pp.1-11
    • /
    • 2018
  • 목적 : 본 연구는 작업치료사의 감정노동과 우울감의 수준을 파악하고, 작업치료사의 감정노동이 우울감에 미치는 영향을 알아보고자 하였다. 연구방법 : 본 연구는 서울과 경기 지역의 병원 및 의원에서 근무하고 있는 임상 작업치료사를 대상으로 하였다. 일반적 특성 및 직업적 특성, 감정노동과 우울 항목으로 구성된 설문지를 통해 조사하였고, 부정확한 응답 8부를 제외한 210부를 대상으로 분석하였다. 감정노동의 요인을 독립변수로 하고, 카이제곱 검정 결과 유의한 결과를 보인 일반적 특성과 직업관련 특성 변수들을 보정변수로 투입하였으며, 우울 여부를 종속변수로 하여 다변량 로지스틱 회귀분석을 실시하였다. 결과 : 감정노동의 구성요소인 감정노동의 빈도(OR 1.699, 95% CI 1.202-2.401), 감정노동에 대한 주의정도(OR 1.436, 95% CI 1.070-1.928), 감정의 부조화(OR 1.866, 95% CI 1.336-2.607)는 모두 우울에 유의한 영향을 나타냈다. 성별에서는 남성보다 여성에서(OR 5.736, 95% CI 1.746-18.846), 1일 근무시간에서는 8시간 이하보다 8시간 초과가(OR 8.609, 95% CI 2.306-32.137), 치료 대상자는 성인보다 아동을 담당하는 작업치료사에서(OR 4.249, 95% CI 1.668-10.824) 우울 가능성이 유의하게 높게 나타났다. 결론 : 작업치료사는 환자와 환자 보호자를 접촉하면서 생기는 감정노동이 우울감에 영향을 미치는 것으로 확인되어, 작업치료사의 우울감을 감소시키기 위한 다양한 예방 활동 및 정책이 필요할 것으로 사료된다.

Comparing Effectiveness Rituximab (Mabthera®) to Other Second-line Biologics for Rheumatoid Arthritis Treatment in Patients Refractory to or Intolerant of First-line Anti-tumor Necrosis Factor Agent: An Observational Study

  • Park, Yong-Wook;Kim, Ki-Jo;Yang, Hyung-In;Yoon, Bo Young;Kim, Sang Hyon;Kim, Seong-Ho;Kim, Jinseok;Oh, Ji Seon;Kim, Wan-Uk;Lee, Yeon-Ah;Choe, Jung-Yoon;Park, Min-Chan;Lee, Sang-Heon
    • Journal of Rheumatic Diseases
    • /
    • 제24권4호
    • /
    • pp.227-235
    • /
    • 2017
  • Objective. Failure of first-line anti-tumor necrosis factor (TNF) agents in in rheumatoid arthritis patients leads to decisions among second-line biologic agents. To better inform these decisions, the therapeutic effectiveness of rituximab is compared with other second-line biologic agents in this observational study. Methods. Between November 2011 and December 2014, study subjects were observed for 12 month periods. Patients with an inadequate response to initial anti-TNF agent received either rituximab or alternative anti-TNF agents (adalimumab/etanercept/infliximab) based on the preference of patients and physicians. The efficacy end point of this study was the change in 28-joint count Disease Activity Score (DAS28) at six and 12 months from baseline. Safety data were also collected. Results. Ninety patients were enrolled in the study. DAS28 at six months did not change significantly whether the patients were treated with rituximab or alternative anti-TNF agents in intention-to-treat analysis (n=34, $-1.63{\pm}0.30$ vs. n=31, $-2.05{\pm}0.34$) and standard population set analysis (n=31, $-1.51{\pm}0.29$ vs. n=24, $-2.21{\pm}0.34$). Similarly, the change in DAS28 at 12 months did not reach statistical significance ($-1.82{\pm}0.35$ in the rituximab vs. $-2.34{\pm}0.44$ in the alternative anti-TNF agents, p=0.2390). Furthermore, the incidences of adverse events were similar between two groups (23.5% for rituximab group vs. 25.8% for alternative anti-TNF agents group, p=0.7851). Conclusion. Despite the limitations of our study, switching to rituximab or alternative anti-TNF agents after failure of the initial TNF antagonist showed no significant therapeutic difference in DAS28 reduction.

두통 초진 환자에서 신경영상검사 소견 (Neuroimaging Findings of First-Visit Headache Patients)

  • 김병수;김수경;김재문;문희수;박광렬;박정욱;손종희;송태진;주민경;차명진;김병건;조수진
    • 대한신경과학회지
    • /
    • 제36권4호
    • /
    • pp.294-301
    • /
    • 2018
  • Background: Neuroimaging can play a crucial role in discovering potential abnormalities to cause secondary headache. There has been a progress in the fields of headache diagnosis and neuroimaging in the past two decades. We sought to investigate neuroimaging findings according to headache disorders, age, sex, and imaging modalities in first-visit headache patients. Methods: We used data of consecutive first-visit headache patients from 9 university and 2 general referral hospitals. The International Classification of Headache Disorders, third edition, beta version was used in headache diagnosis. We finally enrolled 1,080 patients undertook neuroimaging in this study. Results: Among 1,080 patients (mean age: $47.7{\pm}14.3$, female: 60.8%), proportions of headache diagnosis were as follows: primary headaches, n=926 (85.7%); secondary headaches, n=110 (10.2%); and cranial neuropathies and other headaches, n=43 (4.1%). Of them, 591 patients (54.7%) received magnetic resonance imaging (MRI). Neuroimaging abnormalities were found in 232 patients (21.5%), and their proportions were higher in older age groups and male sex. Chronic cerebral ischemia was the most common finding (n=88, 8.1%), whereas 76 patients (7.0%) were found to have clinically significant abnormalities such as primary brain tumor, cancer metastasis, and headache-relevant cerebrovascular disease. Patients underwent MRI were four times more likely to have neuroimaging abnormalities than those underwent computed tomography (33.3% vs. 7.2%, p<0.001). Conclusions: In this study, the findings of neuroimaging differed according to headache disorders, age, sex, and imaging modalities. MRI can be a preferable neuroimaging modality to identify potential causes of headache.

스쿼트 운동 시 적용된 중주파 전기자극이 안쪽빗넓은근과 가쪽넓은근의 근활성도 및 근활성비에 미치는 영향 (Effects of Interfering Current Stimulation on Vastus Medialis Oblique and Vastus Lateralis Activity and Ratio during Squat Exercise)

  • 김충유
    • 대한통합의학회지
    • /
    • 제9권4호
    • /
    • pp.283-289
    • /
    • 2021
  • Purpose : The purpose of this study is to investigate the effect of mid frequency electrical stimulation during squat exercise on the muscle activity and muscle activity ratio of vastus medialis oblique and vastus lateralis, and to prepare scientific basic data for exercise intervention using mid frequency electrical stimulation. Methods : This study was conducted with students from University C located in Busan, and among a total of 123 subjects, 12 subjects who complained of knee joint dysfunction between 80 and 90 points using the Kujala patellofemoral score (KPS) were used. All subjects participated in the experiment for 3 days, and MVIC values were measured for normalization of muscle activity values on the first day. For the two days, participants participated in the experiment and performed squat exercise or squat exercise receiving mid-frequency electrical stimulation in random order. Measurements were taken in the squat position immediately after the squat exercise, and muscle activities of vastus medialis oblique and vastus lateralis were measured. The measured data were compared through the dependent t test, and the statistical significance level was set to .05. Results : According to the results of this study, in the case of applying mid-frequency electrical stimulation together in the ratio of vastus medialis oblique and vastus lateralis muscle activity during squat exercise, higher values were observed compared to the case of not applying mid-frequency electrical stimulation together, and statistically significant. Also, when mid-frequency electrical stimulation was applied to both vastus medialis oblique and vastus lateralis activities during the squat exercise, higher values were shown compared to the case where the mid-frequency electrical stimulation was not applied together, but there was no statistically significant difference. Conclusion : The results of this study reported that mid-frequency electrical stimulation provided to vastus medialis oblique increased the muscle activity ratio of vastus medialis oblique and vastus lateralis. Therefore, the improvement of coordination due to the enhancement of the activity of vastus medialis oblique through mid-frequency electrical stimulation will be more helpful in the treatment of patellofemoral pain syndrome patient. In addition, it is hoped that the electrical stimulation method applied to exercise will be widely used.

Is the Spinal Instability Neoplastic Score Accurate and Reliable in Predicting Vertebral Compression Fractures for Spinal Metastasis? A Systematic Review and Qualitative Analysis

  • Lee, Chang-Hyun;Hong, Jae Taek;Lee, Sun-Ho;Yi, Seong;Sohn, Moon-Jun;Kim, Sung Hwan;Chung, Chun Kee;Korean Spine Oncology Research Society
    • Journal of Korean Neurosurgical Society
    • /
    • 제64권1호
    • /
    • pp.4-12
    • /
    • 2021
  • Spinal metastases can present with varying degrees of mechanical instability. The Spinal Instability Neoplastic Score (SINS) was developed as a tool to assess spinal neoplastic-related instability while helping to guide referrals among oncology specialists. Some previous papers suggested that the SINS was accurate and reliable, while others disagreed with this opinion. We performed a systematic review regarding the SINS to evaluate its accuracy and precision in predicting vertebral compression fractures (VCFs). The 21 included studies investigated a total of 2118 patients. Thirteen studies dealt with the accuracy of SINS to predict post-radiotherapy VCFs, and eight dealt with the precision. Among 13 studies, 11 agreed that the SINS categories showed statistically significant accuracy in predicting VCF. Among eight studies, body collapse was effective for predicting VCFs in six studies, and alignment and bone lesion in two studies. Location has no statistical significance in predicting VCFs in any of the eight studies. The precision of SINS categories was substantial to excellent in six of eight studies. Among the six components of the SINS, the majority of the included studies reported that location showed near perfect agreement; body collapse, alignment, and posterolateral involvement showed moderate agreement; and bone lesion showed fair agreement. Bone lesion showed significant accuracy in predicting VCFs in half of eight studies, but displayed fair reliability in five of seven studies. Although location was indicated as having near perfect reliability, the component showed no accuracy for predicting VCFs in any of the studies and deleting or modifying the item needs to be considered. The SINS system may be accurate and reliable in predicting the occurrence of post-radiotherapy VCFs for spinal metastasis. Some components seem to be substantially weak and need to be revised.